Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by Rigshospitalet, Denmark.
Recruitment status was Not yet recruiting
Information provided by:
First received: November 18, 2005
Last updated: May 31, 2006
Last verified: November 2005
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
||Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.
Primary Outcome Measures:
Secondary Outcome Measures:
| Estimated Enrollment:
| Estimated Study Completion Date:
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus
|Ages Eligible for Study:
||18 Years to 60 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
abortion at gestational age (ultrasound) 14+0 - 20+0
Allergy to cytotec
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00256009
||Lars Alling Møller, MD phd
No publications provided
History of Changes
|Other Study ID Numbers:
||KF 01 279545
|Study First Received:
||November 18, 2005
||May 31, 2006
||Denmark: National Board of Health
Keywords provided by Rigshospitalet, Denmark:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 29, 2014
Reproductive Control Agents
Physiological Effects of Drugs
Abortifacient Agents, Nonsteroidal